Börskollen - Aktier, fonder och ekonominyheter
Börskollen
Populär: Investeringsstrategin som gett en årlig snittavkastning på 12,3 procent – så fungerar den

Pressmeddelanden från Magle Chemoswed

Kurs från TradingView
Visa mer ▼
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts
I förrgår 21:24
Magle Chemoswed
MAGLE GROUP COMPLETES SET-OFF ISSUE TO BONDHOLDERS AND THE DIRECTED SHARE ISSUES RESOLVED UPON BY THE EGMI förrgår 14:40
Magle Chemoswed
Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer02 sep 21:10
Magle Chemoswed
Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure26 aug 14:24
Magle Chemoswed
Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ)21 aug 18:30
Magle Chemoswed
Magle Group announces additional drawdown under bridge loan facility17 aug 14:05
Magle Chemoswed
Disciplinary Committee of Nasdaq Stockholm fines Magle Chemoswed Holding AB (publ) for breach of rulebook12 aug 18:15
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Second Quarter 202611 aug 20:45
Magle Chemoswed
MAGLE CHEMOSWED HOLDING AB (PUBL) ADVANCES PUBLICATION OF THE INTERIM REPORT FOR Q2 202630 jul 15:10
Magle Chemoswed
Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/2028 and its senior secured bonds 2026/202827 jul 09:30
Magle Chemoswed
Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)27 jul 07:45
Magle Chemoswed
The board of Magle Chemoswed Holding AB (publ) proposes that the EGM resolves on voluntary delisting of the company’s shares from Nasdaq First North Growth Market13 jul 14:04
Magle Chemoswed
Magle Chemoswed Holding AB (publ) initiates a written procedure to amend the terms and conditions of its senior secured bonds10 jul 19:04
Magle Chemoswed
MAGLE GROUP HAS RESOLVED ON A RESTRUCTURING OF ITS OUTSTANDING DEBT AND CAPITAL STRUCTURE, INCLUDING DEBT-FOR-EQUITY SWAP, ISSUANCE OF SUPER SENIOR BONDS AND DIRECTED SHARE ISSUES30 jun 21:53
Magle Chemoswed
Magle Group enters into agreement with Danske Bank regarding repayment schedule and agreement with the bondholders committee regarding the requirement for additional capital30 jun 17:24
Magle Chemoswed
Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ)30 jun 13:40
Magle Chemoswed
Magle Chemoswed Holding AB (publ) releases Annual Report for 202526 jun 18:00
Magle Chemoswed
Magle Group Announces Change in Publication Date for Annual Report 202525 jun 21:41
Magle Chemoswed
Magle Group announces deferral of interest payment in respect of its bonds, and update to timing of intended financial restructuring23 jun 21:00
Magle Chemoswed
Magle Group Announces Change in Publication Date for Annual Report 202522 jun 16:24
Magle Chemoswed
Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/202811 jun 22:00
Magle Chemoswed
MAGLE GROUP ANNOUNCES AN UPDATE REGARDING THE KEY PRINCIPLES FROM NEGOTIATIONS WITH BONDHOLDERS07 jun 19:08
Magle Chemoswed
Magle Chemoswed Holding AB – Update on Financing Arrangements and Ongoing Stakeholder Discussions07 jun 15:25
Magle Chemoswed
Magle Group Announces Change in Publication Date for Annual Report 202502 jun 14:28
Magle Chemoswed
Magle Chemoswed Holding AB (publ) initiates a written procedure to amend the terms and conditions of its senior secured bonds 2025/202831 maj 12:00
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For First Quarter 202628 maj 08:32
Magle Chemoswed
Kallelse till årsstämma i Magle Chemoswed Holding AB (publ)27 maj 19:26
Magle Chemoswed
Magle Group enters into a loan facility agreement of up to SEK 60 million26 maj 16:28
Magle Chemoswed
Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ)25 maj 15:00
Magle Chemoswed
Calendar Update of the Annual General Meeting 202611 maj 22:01
Magle Chemoswed
MAGLE GROUP HAS RESOLVED ON A SET-OFF ISSUE TO BONDHOLDERS08 maj 09:30
Magle Chemoswed
Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)05 maj 20:31
Magle Chemoswed
Magle Group announces resignation of board member01 maj 17:26
Magle Chemoswed
Magle Group announces resignation of board members30 apr 18:04
Magle Chemoswed
Magle Group Announces Outcome of Rights Issue28 apr 07:30
Magle Chemoswed
Magle Group Announces Change in Publication Date for Annual Report 202523 apr 20:51
Magle Chemoswed
Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/202814 apr 09:28
Magle Chemoswed
Magle Group Publishes Information Document in Connection with Upcoming Rights Issue10 apr 11:27
Magle Chemoswed
Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB (publ)27 mar 08:30
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 202526 mar 16:35
Magle Chemoswed
Magle Chemoswed Holding AB (publ) initiates written procedure to amend the terms and conditions of its senior secured bonds 2025/202825 mar 21:26
Magle Chemoswed
Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)25 mar 20:46
Magle Chemoswed
MAGLE GROUP’S BOARD OF DIRECTORS HAS RESOLVED ON A RIGHTS ISSUE OF APPROX SEK 40 MILLION AND AGREED A REVISED FINANCING PACKAGE28 feb 18:40
Magle Chemoswed
Magle Chemoswed Holding AB enters into exclusive license agreement for amniotic stem cell technology18 feb 18:00
Magle Chemoswed
Magle Group Issues Profit Warning Ahead of Q4 and Full-Year 2025 Results29 jan 11:18
Magle Chemoswed
Magle Group Announces Strategic Refocus to Strengthen Profitability and Operational Discipline21 jan 13:52
Magle Chemoswed
Magle Group Announces Planned Transition in Chief Operating Officer Role02 jan 13:03
Magle Chemoswed
Magle Group today announces a change in executive leadership16 dec 2025 13:33
Magle Chemoswed
Magle Chemoswed Holding AB announces change of Certified Adviser to Redeye01 dec 2025 15:00
Magle Chemoswed
Magle Group Enters Strategic Distribution Agreement with Rifa Pharma for SmartPAN® and SmartGEL® in India.27 nov 2025 08:30
Magle Chemoswed
Magle Chemoswed Holding Announces Chairman Transition17 nov 2025 14:53
Magle Chemoswed
Magle Group Completes European Medical Device Filing for the Use of EmboCept® S in Genicular Artery Embolisation14 nov 2025 08:30
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Third Quarter 202531 okt 2025 08:30
Magle Chemoswed
Magle Group Announces Revised Publication Date for Q3 2025 Due to Ongoing Consolidation Processes23 okt 2025 15:25
Magle Chemoswed
Magle Group sponsors inaugural VENTI Conference in Tokyo, Japan — supporting innovation in vascular embolotherapy and pain interventions22 okt 2025 08:56
Magle Chemoswed
Magle Biopolymers receives 2026 order showing a material increase in demand for one of its proprietary dextran derivatives20 okt 2025 10:40
Magle Chemoswed
Magle Group announces positive clinical evidence review of EmboCept® S for Genicular Artery Embolisation (GAE); regulatory filing in Europe now in preparation02 okt 2025 07:45
Magle Chemoswed
Magle Group Secures Registration of SmartPAN® in Singapore, Enabling Launch in Pancreatic Surgery01 aug 2025 07:30
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Second Quarter 202529 jul 2025 09:00
Magle Chemoswed
Magle Group’s financial results for the second quarter anticipated to fall short of market expectations.24 jun 2025 17:20
Magle Chemoswed
Magle Group successfully places senior secured bonds of SEK 350 million13 jun 2025 07:30
Magle Chemoswed
Magle Group contemplates issuance of senior secured bonds05 jun 2025 17:54
Magle Chemoswed
The acquisition of all shares in Saving Chlora AB has been completed26 maj 2025 15:00
Magle Chemoswed
Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 26 maj 522 maj 2025 09:56
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For First Quarter 202505 maj 2025 17:30
Magle Chemoswed
Magle Chemoswed Holding AB (publ) Releases Annual Report for 2024.27 apr 2025 18:30
Magle Chemoswed
Malmö, Sweden – Magle Group announces a revised publication date for its 2024 Annual Report, and its Q1 2025 Interim Report.25 apr 2025 16:30
Magle Chemoswed
Correction: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 202425 apr 2025 09:00
Magle Chemoswed
Magle PharmaCept Partners with Pancreatic Cancer Europe PCE to Advance Innovation in Pancreatic Cancer Care24 apr 2025 11:15
Magle Chemoswed
Magle Group Announces Acquisition of Saving Chlora AB24 apr 2025 09:00
Magle Chemoswed
Kallelse till årsstämma i Magle Chemoswed Holding AB (publ)28 mar 2025 14:35
Magle Chemoswed
Magle Group to BioStock: We live by the mantra ‘earn it before you burn it’28 mar 2025 14:35
Magle Chemoswed
Magle Group till BioStock: We live by the mantra ‘earn it before you burn it’27 mar 2025 08:30
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 202424 mar 2025 12:35
Magle Chemoswed
BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator19 mar 2025 08:15
Magle Chemoswed
Magle Group initiates Randomized Controlled Multicenter Trial with leading European university hospitals to explore SmartPAN® efficacy26 feb 2025 18:00
Magle Chemoswed
Ingela Fritzson resigns from the Board of Directors of Magle Group17 feb 2025 09:00
Magle Chemoswed
Magle Group is pleased to announce Magle PharmaCept’s participation in the DPC, German Pancreatic Club congress, set to take place February 27-March 1, 2025, in Heidelberg, Germany.14 feb 2025 08:05
Magle Chemoswed
Magle Group Announces Revised Publication Date for Q4 2024 and Full-Year 2024 Reports Due to Ongoing Consolidation Process09 jan 2025 21:45
Magle Chemoswed
Magle Group offentliggör tilldelning i den riktade emissionen30 dec 2024 12:30
Magle Chemoswed
Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB20 dec 2024 15:30
Magle Chemoswed
Magle Group tillförs cirka 36,8 MSEK i företrädesemissionen16 dec 2024 15:30
Magle Chemoswed
Magle Group offentliggör tilläggsprospekt16 dec 2024 10:40
Magle Chemoswed
Magle Group Approves Multi-Centre Clinical Trial in Genicular Artery Embolisation for Osteoarthritis Pain Relief12 dec 2024 22:45
Magle Chemoswed
Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)12 dec 2024 22:00
Magle Chemoswed
Magle Group beslutar om en villkorad riktad nyemission om upp till cirka 26,6 MSEK10 dec 2024 18:00
Magle Chemoswed
Magle Group offentliggör tilläggsprospekt05 dec 2024 08:50
Magle Chemoswed
Announcement of CFO Petra Jönsson Sjölin’s Resignation05 dec 2024 08:50
Magle Chemoswed
Appointment of Aaron Wong as CFO of Magle Group04 dec 2024 13:00
Magle Chemoswed
Correction: Nomination Committee appointed for the annual general meeting 2025 in Magle Chemoswed Holding03 dec 2024 11:30
Magle Chemoswed
Nomination Committee appointed for the Annual General Meeting 2025 in Magle Chemoswed Holding02 dec 2024 17:30
Magle Chemoswed
Magle Group offentliggör prospekt avseende företrädesemissionen22 nov 2024 08:30
Magle Chemoswed
Magle Group beslutar om företrädesemission om cirka 36,8 MSEK24 okt 2024 08:30
Magle Chemoswed
Magle Chemoswed Holding Reports Financial Results For Third Quarter 202407 okt 2024 11:45
Magle Chemoswed
Fusionen mellan Magle Group och Amniotics är slutförd04 okt 2024 16:00
Magle Chemoswed
Kvittningsemissionen till PRS1 ApS är genomförd04 okt 2024 11:00
Magle Chemoswed
Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB04 okt 2024 09:00
Magle Chemoswed
Magle Group beslutar om emission av vederlagsaktier02 okt 2024 09:00
Magle Chemoswed
Magle Chemoswed and I2Pure Announce Joint Venture in Wound Care23 sep 2024 13:30
Magle Chemoswed
Bolagsverket har lämnat tillstånd att verkställa fusionsplanen mellan Magle Group och Amniotics18 sep 2024 09:15
Magle Chemoswed
Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ)